Optic Nerve Sheath Diameter Measurement in Cleft Palate Repair

Sponsor
Karadeniz Technical University (Other)
Overall Status
Completed
CT.gov ID
NCT04718558
Collaborator
(none)
30
1
9
3.3

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effect of the Boyle-Davis mouth opener, which is routinely used in cleft palate surgery, on intracranial pressure by USG-guided optic nerve sheath diameter measurement, which is a non-invasive method with proven effectiveness and reliability in recent years.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Non-syndromic cleft lip and / or palate is a complex congenital defect that results from multiple genetic and environmental factors. It is also one of the most common congenital malformations. Cleft defects require early surgical repair to minimize nutritional difficulties and ensure optimum speech function. The Boyle-Davis mouth opener used in cleft palate surgery consists of tongue blade, mouth opener and suspension system and is used to fix the endotracheal tube in the midline and provide excellent surgical vision during the operation. However, it can cause complications such as dental injuries, laryngospasm, and displacement of the tracheal tube.

    Undesirable effects such as changes in heart rate and increases in intracranial pressures may occur during endotracheal intubation. These hemodynamic responses are thought to be due to increased sympathoadrenal activity. Laryngoscopy without tracheal intubation has been shown to increase high catecholamine levels and blood pressure, suggesting that sympathoadrenergic response occurs more frequently due to stimulation of the supraglottic region. Although the Boyle-Davis mouth opener provides an advantage for access to the intraoral cavity, its insertion causes significant increases in intracranial pressure (ICP) and intraocular pressures by causing hemodynamic changes similar to laryngoscopy.

    In recent studies, measurement of optic nerve sheath diameter with ultrasonography, which is a non-invasive method, is frequently used in the detection of intracranial pressure increases. The optic nerve is a part of the central nervous system and is covered with a dural sheath. Pressure changes in the intracranial region are similar to the pressure in the infraorbital subarachnoid space surrounding the optic nerve. In clinical studies, it has been shown that changes in intracranial pressure correlate with the optic nerve sheath diameter measured by ultrasonography. Compared to other diagnostic methods, measurement of the diameter of the optic nerve sheath is an inexpensive, easy-to-apply and non-invasive method. In our study, we aimed to determine the intracranial pressure changes that may occur due to the use of mouth gag in cleft palate surgeries by measuring the optic nerve sheath diameter with USG, which is a non-invasive method.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    30 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of the Effect of Boyle-Davis Mouth Gape on Intracranial Pressure in Patients With Cleft Palate Repair by Measuring Optic Nerve Sheath Diameter
    Actual Study Start Date :
    Oct 1, 2020
    Actual Primary Completion Date :
    May 15, 2021
    Actual Study Completion Date :
    Jul 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Patients aged between 3-24 month and undergoing cleft palate surgery

    Outcome Measures

    Primary Outcome Measures

    1. change in optic nerve sheath diameter [After general anesthesia induction, after endotracheal intubation, after mouth gag insertion (primary timepoint), 20 minutes, 40 minutes, 60 minutes after mouth gag insertion]

      Change in optic nerve sheath diameter as assessed by rapid ultrasound scan before general anesthesia, after intubation, 1 minute, 10 minutes, 20 minutes, 40 minutes, 60 minutes after mouth gag is inserted and after mouth gape is removed

    Secondary Outcome Measures

    1. Change in heart rate [After general anesthesia induction, after endotracheal intubation, after mouth gag insertion (primary timepoint), 20 minutes, 40 minutes, 60 minutes after mouth gag insertion]

      Change in heart rate by using electrocardiogram on the anesthesia workstation

    2. Change in End tidal CO2 [After general anesthesia induction, after endotracheal intubation, after mouth gag insertion (primary timepoint), 20 minutes, 40 minutes, 60 minutes after mouth gag insertion]

      Change in End tidal CO2 by using capnography on the anesthesia workstation

    3. Change in Peak inspiratory pressure (PIP) workstation [After general anesthesia induction, after endotracheal intubation, after mouth gag insertion (primary timepoint), 20 minutes, 40 minutes, 60 minutes after mouth gag insertion]

      Change in Peak inspiratory pressure (PIP) by using monitoring on the anesthesia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Months to 24 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged between 3-24 month and with an ASA physical status I-II and undergoing cleft palate surgery will be included to the study.
    Exclusion Criteria:
    • Exclusion criteria will be preexisting acute or chronic eye disease,

    • History of eye surgery, use of drugs known to influence intraocular pressure (IOP) (ß blockers, Ca channel blockers, statins and nitrates)

    • Conditions that may cause known intracranial pressure changes (cerebrovascular event, bleeding, an intracranial tumor, etc.)

    • patients' parental refusal

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Karadeniz Technical University Trabzon Turkey 61080

    Sponsors and Collaborators

    • Karadeniz Technical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ali AKDOĞAN, assistant professor, Karadeniz Technical University
    ClinicalTrials.gov Identifier:
    NCT04718558
    Other Study ID Numbers:
    • 2020/271
    First Posted:
    Jan 22, 2021
    Last Update Posted:
    Nov 3, 2021
    Last Verified:
    Nov 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ali AKDOĞAN, assistant professor, Karadeniz Technical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 3, 2021